Clinical Trial 41363

share

Pearland, TX 77584


Study Summary:

A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older With Asthma


Qualified Participants Must:
  1. Be female or male aged ≥4 years at the time of informed consent
  2. Have a physician diagnosis of asthma documented for at least 1 year
  3. Have a documented history of at least 1 severe asthma exacerbation within 12 months before Visit 1
  4. Be receiving 1 of the following scheduled asthma maintenance therapies for 3 months with stable dosing for at least the last 4 weeks before Visit 1:

    • Medium-to-high-dose inhaled corticosteroid (ICS)
    • Medium-to-high-dose ICS and 1 additional maintenance therapy from the following: leukotriene receptor antagonists (LTRA), long-acting muscarinic antagonists (LAMA), or theophylline
    • Low-to-high-dose ICS in combination with long-acting β2-adrenoreceptor agonist (LABA) with or without one additional maintenance therapy from the following: LTRA, LAMA, or theophyllinA documented history of at least 1 severe asthma exacerbation within 12 months before Visit 1


Qualified Participants May Receive:

Compensation of $50 per visit for time and travel

All study-related procedures at no cost to the participant


Study is Available At:

Shadow Creek Medical Clinic - Pearland

11021 Shadow Creek Pkwy #102, Pearland, TX 77584

 


If you or someone you care for is interested in participating in this clinical trial and lives within 35 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.